ArticleCancer reports (Hoboken, N.J.)2023

Prognostic factors of toxicity of immune checkpoint inhibitors in nonsmall cell lung cancer and small cell lung cancer patients: The ToxImmune study.

Francoise Difoum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.